Talking Precision Medicine

Launching the Hubble Telescope to Cure Cancer with Charlie Silver and Nigel Beard | Talking Precision Medicine #17

av Talking Precision Medicine | Publicerades 1/9/2020

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine.  This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics.  Today our guests are Charlie Silver and Nigel Beard. Charlie is CEO, and Nigel CTO, of Mission Bio. Mission Bio is a single-cell analysis platform company empowering researchers to cure cancer. They are the first company to deliver simultaneous measurement of the genotype and phenotype at single-cell resolution. In this episode, we talk about the audacious mission at Mission Bio, and how their groundbreaking platform enables a whole new set of questions to be answered in cancer research. We also go deep on potential clinical applications and the future of single-cell multi-omic datasets.

Om Podcasten

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.